DiLillo, D. J., Olson, K., Mohrs, K., Meagher, T. C., Bray, K., Sineshchekova, O., . . . Kirshner, J. R. (2021). A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells. Blood Adv.
Citação norma ChicagoDiLillo, David J., et al. "A BCMAxCD3 Bispecific T Cell–engaging Antibody Demonstrates Robust Antitumor Efficacy Similar to That of Anti-BCMA CAR T Cells." Blood Adv 2021.
MLA CitationDiLillo, David J., et al. "A BCMAxCD3 Bispecific T Cell–engaging Antibody Demonstrates Robust Antitumor Efficacy Similar to That of Anti-BCMA CAR T Cells." Blood Adv 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.